• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经肺途径给药的联合利福平制剂治疗豚鼠模型结核病的疗效

Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model.

作者信息

Garcia-Contreras Lucila, Sethuraman Vasu, Kazantseva Masha, Hickey Anthony

机构信息

Division of Molecular Pharmaceutics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Department of Pharmaceutical Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.

出版信息

Pharmaceutics. 2021 Aug 21;13(8):1309. doi: 10.3390/pharmaceutics13081309.

DOI:10.3390/pharmaceutics13081309
PMID:34452270
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8400142/
Abstract

Liposomes, as vehicles alone or in combination with rifampicin (RIF) microparticles (RMs), were evaluated as vehicles to enhance the permeation of RIF into granulomas. RIF liposomes (RLs) were extruded through a 0.1 µm polypropylene membrane. RMs were prepared by the solvent evaporation method. Four weeks after infection, guinea pigs (GPs) were assigned to groups treated with a combination of RM-RLs or RLs alone. RLs were nebulized after extrusion whereas RMs were suspended in saline and nebulized to GPs in a nose-only inhalation chamber. Necropsy was performed after the treatment; the lungs and spleen were resected for bacteriology. RLs had mean diameters of 137.1 ± 33.7 nm whereas RMs had a projected area diameter of 2.48 µm. The volume diameter of RMs was 64 ± 1 µm, indicating that RMs were aggregated. The treatment of TB-infected GPs with RLs significantly reduced their lung bacterial burden and wet spleen weight compared with those treated with blank liposomes. The treatment of TB-infected animals with RM-RLs also reduced their lung bacterial burden and wet spleen weight even though these reductions were not statistically different. Based on these results, the permeation of RIF into granulomas appears to be enhanced when encapsulated into liposomes delivered by the pulmonary route.

摘要

脂质体作为单独的载体或与利福平(RIF)微粒(RMs)联合使用,被评估为增强RIF渗透到肉芽肿中的载体。RIF脂质体(RLs)通过0.1μm聚丙烯膜挤出。RMs采用溶剂蒸发法制备。感染四周后,将豚鼠(GPs)分为接受RM-RLs联合治疗或单独使用RLs治疗的组。RLs在挤出后进行雾化,而RMs悬浮在盐水中并在仅通过鼻腔吸入的舱室中对GPs进行雾化。治疗后进行尸检;切除肺和脾脏进行细菌学检查。RLs的平均直径为137.1±33.7nm,而RMs的投影面积直径为2.48μm。RMs的体积直径为64±1μm,表明RMs发生了聚集。与用空白脂质体治疗的豚鼠相比,用RLs治疗结核感染的豚鼠显著降低了其肺部细菌负荷和脾脏湿重。用RM-RLs治疗结核感染的动物也降低了其肺部细菌负荷和脾脏湿重,尽管这些降低在统计学上没有差异。基于这些结果,当RIF被包裹在通过肺部途径递送的脂质体中时其渗透到肉芽肿中的能力似乎增强了。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/71839c472ae6/pharmaceutics-13-01309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/b832d82b00e2/pharmaceutics-13-01309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/e498dc78773f/pharmaceutics-13-01309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/71839c472ae6/pharmaceutics-13-01309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/b832d82b00e2/pharmaceutics-13-01309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/e498dc78773f/pharmaceutics-13-01309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e75/8400142/71839c472ae6/pharmaceutics-13-01309-g003.jpg

相似文献

1
Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model.经肺途径给药的联合利福平制剂治疗豚鼠模型结核病的疗效
Pharmaceutics. 2021 Aug 21;13(8):1309. doi: 10.3390/pharmaceutics13081309.
2
Evaluation of dosing regimen of respirable rifampicin biodegradable microspheres in the treatment of tuberculosis in the guinea pig.可吸入性利福平可生物降解微球给药方案对豚鼠结核病治疗效果的评估
J Antimicrob Chemother. 2006 Nov;58(5):980-6. doi: 10.1093/jac/dkl369. Epub 2006 Sep 13.
3
Pharmacokinetics of Inhaled Rifampicin Porous Particles for Tuberculosis Treatment: Insight into Rifampicin Absorption from the Lungs of Guinea Pigs.用于结核病治疗的吸入式利福平多孔颗粒的药代动力学:对豚鼠肺部利福平吸收的深入了解。
Mol Pharm. 2015 Aug 3;12(8):2642-50. doi: 10.1021/acs.molpharmaceut.5b00046. Epub 2015 May 26.
4
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.含利福平的可吸入聚乳酸-羟基乙酸共聚物微球用于治疗结核病:在传染病模型中的筛选
Pharm Res. 2001 Sep;18(9):1315-9. doi: 10.1023/a:1013094112861.
5
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.用于实验性结核病的基于聚(DL-丙交酯-共-乙交酯)纳米颗粒的可吸入持续给药系统
J Antimicrob Chemother. 2003 Dec;52(6):981-6. doi: 10.1093/jac/dkg477. Epub 2003 Nov 12.
6
Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats.利福平微粒:白化大鼠肺泡巨噬细胞药物摄取、吞噬活性及毒性研究中肺部给药途径与口服给药途径的比较
Drug Deliv. 2014 Sep;21(6):406-11. doi: 10.3109/10717544.2013.851302. Epub 2013 Nov 12.
7
Airways delivery of rifampicin microparticles for the treatment of tuberculosis.用于治疗结核病的利福平微粒的气道给药
J Antimicrob Chemother. 2001 Sep;48(3):431-4. doi: 10.1093/jac/48.3.431.
8
Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.口服卡介苗里约热内卢株能提供与皮内注射卡介苗丹麦株相当的结核保护作用,但病理变化减轻。
Vaccine. 2010 Oct 8;28(43):7109-16. doi: 10.1016/j.vaccine.2010.07.087. Epub 2010 Aug 12.
9
[The animal experimental study on rifampicin-dependent Mycobacterium tuberculosis].[利福平依赖型结核分枝杆菌的动物实验研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Sep;29(9):617-21.
10
[Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].[东京172株卡介苗在豚鼠肺结核模型中的保护效力]
Kekkaku. 2000 May;75(5):379-88.

引用本文的文献

1
Recent advancements in drug development for pulmonary tuberculosis.肺结核药物研发的最新进展。
Arch Microbiol. 2025 Aug 30;207(10):245. doi: 10.1007/s00203-025-04415-y.
2
Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against in Infected Macrophages and Mice.评估用于吸入的创新型干粉剂,其为针对受感染巨噬细胞和小鼠的协同组合。
Pharmaceutics. 2025 May 27;17(6):705. doi: 10.3390/pharmaceutics17060705.
3
Breaking barriers: The potential of nanosystems in antituberculosis therapy.突破障碍:纳米系统在抗结核治疗中的潜力

本文引用的文献

1
Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.载多柔比星脂质体靶向给药治疗 Her-2+乳腺癌。
AAPS PharmSciTech. 2020 Jul 21;21(6):202. doi: 10.1208/s12249-020-01743-8.
2
Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy.优化多西紫杉醇在脂质体中的载药条件:为转移性乳腺癌化疗提出潜在产品。
Sci Rep. 2020 Mar 27;10(1):5569. doi: 10.1038/s41598-020-62501-1.
3
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.耐多药肺结核的治疗。
Bioact Mater. 2024 May 17;39:106-134. doi: 10.1016/j.bioactmat.2024.05.013. eCollection 2024 Sep.
4
The Pharmacokinetics of CPZEN-45, a Novel Anti-Tuberculosis Drug, in Guinea Pigs.新型抗结核药物CPZEN-45在豚鼠体内的药代动力学
Pharmaceutics. 2023 Dec 12;15(12):2758. doi: 10.3390/pharmaceutics15122758.
5
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.用于结核病治疗的先进药物输送和治疗策略。
J Nanobiotechnology. 2023 Nov 9;21(1):414. doi: 10.1186/s12951-023-02156-y.
6
Combined System for the Simultaneous Delivery of Levofloxacin and Rifampicin: Structural and Functional Properties and Antibacterial Activity.左氧氟沙星和利福平同步递送联合系统:结构与功能特性及抗菌活性
J Funct Biomater. 2023 Jul 20;14(7):381. doi: 10.3390/jfb14070381.
N Engl J Med. 2020 Mar 5;382(10):893-902. doi: 10.1056/NEJMoa1901814.
4
Incidence Rates for Tuberculosis Among HIV Infected Patients in Northern Tanzania.坦桑尼亚北部HIV感染患者的结核病发病率
Front Public Health. 2019 Oct 24;7:306. doi: 10.3389/fpubh.2019.00306. eCollection 2019.
5
Trends in Mortality From Human Immunodeficiency Virus Infection, 1984-2016: An Autopsy-Based Study.1984-2016 年人类免疫缺陷病毒感染死亡率趋势:基于尸检的研究。
Arch Pathol Lab Med. 2020 May;144(5):572-579. doi: 10.5858/arpa.2019-0144-OA. Epub 2019 Aug 28.
6
Optimization and Characterization of Thymoquinone-Loaded Liposomes with Enhanced Topical Anti-inflammatory Activity.丁香酚载脂微球的优化及表征及其增强的局部抗炎活性。
AAPS PharmSciTech. 2018 Nov;19(8):3490-3500. doi: 10.1208/s12249-018-1166-1. Epub 2018 Sep 14.
7
Targeting pulmonary tuberculosis using nanocarrier-based dry powder inhalation: current status and futuristic need.基于纳米载体的干粉吸入治疗肺结核:现状与未来需求。
J Drug Target. 2019 Jan;27(1):12-27. doi: 10.1080/1061186X.2018.1455842. Epub 2018 Apr 3.
8
Development of Liposomal Ciprofloxacin to Treat Lung Infections.用于治疗肺部感染的脂质体环丙沙星的研发。
Pharmaceutics. 2016 Mar 1;8(1):6. doi: 10.3390/pharmaceutics8010006.
9
Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions.脂质体两性霉素B(安必素(®)):药代动力学、药效学、临床经验及未来方向综述
Drugs. 2016 Mar;76(4):485-500. doi: 10.1007/s40265-016-0538-7.
10
A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis.一种用于治疗结核病的干粉形式的载利福平脂质体肺部给药的新方法。
Lung India. 2015 Jul-Aug;32(4):331-8. doi: 10.4103/0970-2113.159559.